von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support.
作者信息
Nascimbene Angelo, Hilton Tristan, Konkle Barbara A, Moake Joel L, Frazier O H, Dong Jing-Fei
机构信息
Center for Advanced Heart Failure, University of Texas at Houston, Houston, Texas.
BloodWorks Northwest Research Institute, Seattle, Washington.
出版信息
J Heart Lung Transplant. 2017 Apr;36(4):477-479. doi: 10.1016/j.healun.2017.01.010. Epub 2017 Jan 13.
Abstract
摘要
相似文献
1
von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support.左心室辅助装置支持下患者体内ADAMTS - 13对血管性血友病因子的蛋白水解作用
J Heart Lung Transplant. 2017 Apr;36(4):477-479. doi: 10.1016/j.healun.2017.01.010. Epub 2017 Jan 13.
2
Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.左心室辅助装置导致病理性血管性血友病因子降解是通过两种不同的机制发生的：机械破坏和酶切。
J Thorac Cardiovasc Surg. 2015 Jan;149(1):281-9. doi: 10.1016/j.jtcvs.2014.09.031. Epub 2014 Sep 18.
3
Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.HeartWare心室辅助装置对血管性血友病因子的影响：比利时一个学术中心的研究结果
BMC Cardiovasc Disord. 2016 Aug 2;16(1):155. doi: 10.1186/s12872-016-0334-z.
4
von Willebrand factor disruption and continuous-flow circulatory devices.血管性血友病因子的破坏与连续流循环装置。
J Heart Lung Transplant. 2017 Nov;36(11):1155-1163. doi: 10.1016/j.healun.2017.06.004. Epub 2017 Jun 12.
5
Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.强力霉素抑制 ADAMTS-13 可减少超高生理切应力下 von Willebrand 因子的降解：左心室辅助装置相关出血的治疗意义。
JACC Heart Fail. 2015 Nov;3(11):860-9. doi: 10.1016/j.jchf.2015.06.016. Epub 2015 Oct 7.
6
Preservation of von Willebrand factor multimers and function in patients with an EVAHEART centrifugal-type, continuous-flow left ventricular assist device.使用EVAHEART离心式连续流左心室辅助装置的患者中血管性血友病因子多聚体的保存及其功能
J Heart Lung Transplant. 2017 Jul;36(7):814-817. doi: 10.1016/j.healun.2017.04.004. Epub 2017 Apr 19.
7
Quantification of Von Willebrand Factor Cleavage by adamts-13 in Patients Supported by Left Ventricular Assist Devices.左心室辅助装置支持的患者中 ADAMTS-13 对血管性血友病因子裂解的定量分析。
ASAIO J. 2017 Nov/Dec;63(6):849-853. doi: 10.1097/MAT.0000000000000602.
8
A new spin on acquired von Willebrand factor deficiency during continuous-flow left ventricular assist device support.
J Thorac Cardiovasc Surg. 2015 Jan;149(1):289-90. doi: 10.1016/j.jtcvs.2014.09.052. Epub 2014 Sep 23.
9
Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.左心室辅助装置（LVAD）导致的获得性血管性血友病因子缺乏是依赖于ADAMTS-13和血小板的。
Thromb Res. 2016 Jan;137:196-201. doi: 10.1016/j.thromres.2015.11.002. Epub 2015 Nov 10.
10
Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices.基于抗体对循环辅助装置介导的血管性血友病因子降解的预防作用
Thromb Haemost. 2014 Nov;112(5):1014-23. doi: 10.1160/TH14-02-0148. Epub 2014 Jul 17.
引用本文的文献
1
Hemocompatibility and biophysical interface of left ventricular assist devices and total artificial hearts.左心室辅助装置和全人工心脏的血液相容性和生物物理界面。
Blood. 2024 Feb 22;143(8):661-672. doi: 10.1182/blood.2022018096.
2
ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.在机械循环支持装置植入期间用 ADAMTS13 抑制物治疗获得性血管性血友病综合征。
J Thromb Haemost. 2022 Dec;20(12):2797-2809. doi: 10.1111/jth.15889. Epub 2022 Oct 17.
3
Hyperadhesive von Willebrand Factor Promotes Extracellular Vesicle-Induced Angiogenesis: Implication for LVAD-Induced Bleeding.高黏附性血管性血友病因子促进细胞外囊泡诱导的血管生成：对左心室辅助装置诱导出血的影响
JACC Basic Transl Sci. 2022 Mar 28;7(3):247-261. doi: 10.1016/j.jacbts.2021.12.005. eCollection 2022 Mar.
4
A Flow Induced Autoimmune Response and Accelerated Senescence of Red Blood Cells in Cardiovascular Devices.血流诱导的自身免疫反应和心血管器械中红细胞的加速衰老。
Sci Rep. 2019 Dec 19;9(1):19443. doi: 10.1038/s41598-019-55924-y.
5
Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device.心室辅助装置患者获得性血管性血友病综合征
Front Med (Lausanne). 2019 Feb 5;6:7. doi: 10.3389/fmed.2019.00007. eCollection 2019.
6
Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method.台式 von Willebrand 因子检测：比较商业上可用的心室辅助设备，并评估标准化检测方法的变量。
ASAIO J. 2019 Jul;65(5):481-488. doi: 10.1097/MAT.0000000000000849.
7
von Willebrand factor enhances microvesicle-induced vascular leakage and coagulopathy in mice with traumatic brain injury.血管性血友病因子增强创伤性脑损伤小鼠微泡诱导的血管渗漏和凝血病。
Blood. 2018 Sep 6;132(10):1075-1084. doi: 10.1182/blood-2018-03-841932. Epub 2018 Jun 25.
8
Quantification of Von Willebrand Factor Cleavage by adamts-13 in Patients Supported by Left Ventricular Assist Devices.左心室辅助装置支持的患者中 ADAMTS-13 对血管性血友病因子裂解的定量分析。
ASAIO J. 2017 Nov/Dec;63(6):849-853. doi: 10.1097/MAT.0000000000000602.
本文引用的文献
1
Acquired von Willebrand syndrome associated with left ventricular assist device.与左心室辅助装置相关的获得性血管性血友病综合征
Blood. 2016 Jun 23;127(25):3133-41. doi: 10.1182/blood-2015-10-636480. Epub 2016 May 3.
2
Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.患有离心或轴向连续血流左心室辅助装置的患者获得性血管性血友病综合征。
JACC Heart Fail. 2014 Apr;2(2):141-5. doi: 10.1016/j.jchf.2013.10.008.
3
Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.连续性血流心室辅助装置使用者获得性血管性血友病。
Ann Thorac Surg. 2010 Oct;90(4):1263-9; discussion 1269. doi: 10.1016/j.athoracsur.2010.04.099.
4
Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device.
J Heart Lung Transplant. 2005 Jan;24(1):105-9. doi: 10.1016/j.healun.2003.10.018.
5
Zotero 插件